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AbstrAct
BMAL1 and RORα are major regulators of the circadian molecular oscillator. 
Since previous work in other cell types has shown cross talk between circadian 
rhythm genes and hypoxic signaling, we investigated the role of BMAL1 and RORα in 
controlling HIF-1-dependent transcriptional responses in NP cells that exist in the 
physiologically hypoxic intervertebral disc. HIF-1-dependent HRE reporter activity 
was further promoted by co-transfection with either BMAL1 or RORα. In addition, 
stable silencing of BMAL1 or inhibition of RORα activity resulted in decreased HRE 
activation. Inhibition of RORα also modulated HIF1α-TAD activity. Interestingly, 
immunoprecipitation studies showed no evidence of BMAL1, CLOCK or RORα binding 
to HIF-1α in NP cells. Noteworthy, stable silencing of BMAL1 as well as inhibition of 
RORα decreased expression of select HIF-1 target genes including VEGF, PFKFB3 and 
Eno1. To delineate if BMAL1 plays a role in maintenance of disc health, we studied 
the spinal phenotype of BMAL1-null mice. The lumbar discs of null mice evidenced 
decreased height, and several parameters associated with vertebral trabecular bone 
quality were also affected in nulls. In addition, null animals showed a higher ratio of 
cells to matrix in NP tissue and hyperplasia of the annulus fibrosus. Taken together, 
our results indicate that BMAL1 and RORα form a regulatory loop in the NP and control 
HIF-1 activity without direct interaction. Importantly, activities of these circadian 
rhythm molecules may play a role in the adaptation of NP cells to their unique niche.
IntroductIon
The intervertebral disc is a complex tissue that 
permits a range of motion between adjacent vertebrae and 
accommodates high biomechanical forces in the spine. It 
consists of an outer fibrocartilaginous annulus fibrosus 
(AF) that encloses a gel-like nucleus pulposus (NP). 
Intervertebral discs exhibit diurnal changes in height and 
composition. This is caused by high compressive loading 
on the disc throughout the day that results in efflux of fluid 
from the tissues. At night, under low loading conditions, 
osmotic pressure provides a driving force to imbibe fluid 
into the disc [1-3]. Several studies have shown that NP 
cells respond to changes in osmotic loading by altering 
their gene expression and anabolic activities [4-6]. 
Noteworthy, NP tissue is also completely avascular and 
thus cells are adapted to survive in a hypoxic environment 
[7-12]. Previous reports clearly show that HIF-1α is a 
critical factor for NP cell survival [13] and drives their 
glycolytic metabolism [7-9]. Our group has previously 
shown that HIF-1α regulation in NP cells is unique. 
Particularly, there is robust HIF-1α expression even under 
normoxic conditions and its expression is not appreciably 
induced under hypoxia [7-12].
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BMAL1 (brain and muscle ARNT-like1) and 
CLOCK are basic helix-loop-helix-PAS (bHLH-PAS) 
transcriptional factors and major components of the 
circadian molecular oscillator [14-16]. BMAL1 and 
CLOCK form a heterodimer and, by binding to E-box 
motifs in promoters, stimulate transcription and translation 
of cryptochrome (CRY) and period (PER) family 
members. In turn, these genes inhibit BMAL1:CLOCK 
activity through formation of repressive complexes [17, 
18]. Another important regulatory loop that controls 
circadian clock is made up of BMAL1, Retinoic acid 
receptor-related Orphan Receptor (ROR)-α and REV-
ERBα, a transcriptional repressor [15, 19, 20]. RORα and 
REV-ERBα competitively bind ROR binding sequences 
(RORE) in the BMAL1 promoter controlling its levels; 
meanwhile, RORα and REV-ERBα transcript levels are 
controlled by BMAL1:CLOCK [15, 16, 21]. HIF-α and 
HIF-β (ARNT) proteins also belong to the mammalian 
bHLH-PAS family [22]. The function of BMAL1 and 
RORα in controlling hypoxic HIF-1 activity through 
protein-protein interaction has been reported in certain 
cell types [23-26] indicating that BMAL1 and RORα may 
promote HIF-1α target gene expression. However, whether 
a relationship between HIF-1α and circadian regulators 
BMAL1 and RORα exists in NP cells is not known. 
In this paper, we use in vitro and in vivo approaches 
to test the hypotheses that BMAL1 and RORα control 
hypoxia and HIF-1- dependent transcriptional responses in 
NP cells, and dysregulation of BMAL1 would compromise 
disc health. We show here, for the first time, that BMAL1 
and RORα modulate HIF-1α transcriptional activity and 
influence HIF-1α target genes expression in NP cells. 
Moreover, in vivo studies using BMAL1 null mice suggest 
that BMAL1 deficiency may alter disc structure and 
function. Taken together, our findings suggest that both 
BMAL1 and RORα are important regulators of NP cell 
function.
results
expression analysis of bMAl1 and other related 
factors in nP cells
To investigate expression of BMAL1 in the 
intervertebral disc, we stained sections of rat discs with 
antibodies against BMAL1 (Figure 1A). The results 
show prominent expression of BMAL1 in NP tissue with 
many cells evidencing nuclear localization. Western blot 
was used to analyze the presence of BMAL1 and RORα 
proteins in NP tissues isolated from 3 rats. The expression 
of both BMAL1 and RORα was evident in NP tissue 
(Figure 1B). In addition, we measured mRNA expression 
of BMAL1 and RORα in NP and AF compartments of 
the disc. Both tissues indeed expressed BMAL1 and 
RORα transcripts (Figure 1C). To evaluate the effect of 
hypoxia on expression of BMAL1 and other ARNT family 
members, as well as important circadian rhythm genes, 
we measured mRNA and protein expression in NP cells 
cultured under hypoxia using qRT-PCR (Figure 1D) and 
Western blot analysis (Figure 1E). Our results show that 
mRNA expression of ARNT (HIF-1β), ARNT2, BMAL1, 
ARNTL2, RORα and CLOCK did not significantly change 
under hypoxia (Figure1D). While there was a trend of 
increased protein levels of BMAL1 and RORα under 
hypoxia, it failed to reach statistical significance (Figure 
1F, 1G).
bMAl1 synergizes HIF-1 dependent Hre 
activity in nP cells
We evaluated the effect of BMAL1 on activity 
of a HIF-responsive luciferase reporter (HRE-Luc). 
Co-transfection of BMAL1 with a low dose of HIF-1α 
promoted HIF-1 mediated activation of the HRE reporter 
under both normoxia and hypoxia (Figure 2A and 2B). 
A similar increase in activity was seen when ARNT, but 
not ARNT2, was co-transfected with HIF-1α (Figure 2A 
and 2B). However, addition of BMAL1 or ARNT alone 
had little effect on HRE activity. We then measured dose-
dependency of BMAL1 or ARNT on HRE reporter activity 
driven by a sub optimal dose of HIF-1 (Figure 2C-2F). 
There was a trend of increasing HRE activity when 50 ng 
and 100 ng of BMAL1 or ARNT were co-transfected with 
HIF-1α, however a significant change in HRE activity 
was noted when BMAL1 (Figure 2C and 2D) and ARNT 
(Figure 2E and 2F) were used at 150 ng. All results were 
compared with HIF-1α treatment alone. 
bMAl1 controls HIF-1 activity without affecting 
HIF-α-TAD function
Due to the previously reported contribution of 
BMAL1 in controlling HIF-1 and HIF-2 function in 
other cell types [23-25, 27], we evaluated mechanisms 
by which BMAL1 controlled HIF-1 activity in NP cells. 
First, we stably knocked down BMAL1 in rat NP cells 
via transduction of lentiviral shRNA. Western blot and 
densitometric analysis confirmed that protein levels of 
BMAL1 and RORα, a known target of BMAL1, were 
lower in BMAL1-silenced NP cells under both hypoxia 
and normoxia (Figure 3A -3C). Moreover, activity of 
HIF-1α, as measured by HRE reporter, was significantly 
suppressed in BMAL1-silenced NP cells (Figure 3D). To 
determine if BMAL1 controlled HIF-α-TAD function, we 
measured TAD activity following BMAL1 overexpression. 
Results clearly showed that overexpression of BMAL1 did 
not result in significant change in activity of HIF-1α-C-
TAD (Figure 3E), HIF-1α-N-TAD (Figure 3F), as well as 
HIF-2α-TAD (Figure 3G) regardless of oxygen tension.
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Figure 1: expression analysis of bMAl1 and other related factors in nP cells. A. Immunohistochemical localization of 
BMAL1 in rat intervertebral disc. Sagittal sections of the mature rat intervertebral disc, immunostained with BMAL1 antibody, showed 
prominent nuclear expression in NP tissue. b. Western blot analysis of BMAL1 and RORα expression in NP tissues isolated from three rats 
showed positive expression for both the proteins. c. qRT-PCR analysis of BMAL-1 and RORα mRNA expression from NP and AF tissues 
from rat discs (n=3 animals/group) d. qRT-PCR analysis of BMAL1, RORα, ARNT, ARNT2, ARNTL2 and CLOCK expression in rat NP 
cells cultured under hypoxia (1% O2). None of the genes showed significant increase in hypoxia. e. Western blot analysis of BMAL1 and 
RORα in NP cells cultured under hypoxia. F., G. Densitometric analysis of multiple blots shown in (E) above. No significant differences 
were seen between normoxic and hypoxic levels of BMAL1 and RORα. Data is represented as mean ± SE, n=3, p<0.05.
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RORα controls HIF-1 transcriptional activity and 
tAd function in nP cells
Since we observed that RORα expression was under 
the control of BMAL1 in NP cells, we evaluated the effect 
of RORα on HIF activity. When co-transfected under 
normoxia, there was a synergistic effect between RORα 
(50-150 ng) and HIF-1α on HRE reporter activity as 
compared to HIF-1α alone (Figure 4A). On the other hand, 
while a trend of increasing activity was seen in hypoxia 
at 50 and 100 ng of RORα, a significant synergistic 
increase in HIF-1-dependent HRE activity was only noted 
at the highest dose of 150 ng (Figure 4B). Importantly, 
regardless of the oxemic tension, RORα alone did not 
increase HRE activity at any of the doses tested. 
To follow the RORα gain-of-function experiments, 
we performed loss-of-function experiments to delineate 
effects of RORα inhibition on HIF activity. For this 
purpose, we employed a highly specific, cell permeable, 
small molecular RORα activity inhibitor ML176 [28, 29]. 
Treatment of NP cells under both normoxia and hypoxia 
with increasing dose of ML176 (2-10 µM) resulted in a 
robust decrease in endogenous HIF activity at all doses 
as measured by HRE reporter activity (Figure 4C, 4D). 
We then measured HIF-α-TAD function in NP cells treated 
Figure 2: bMAl1 synergizes HIF-1 dependent Hre activity in nP cells. A., b. Evaluation of HRE activity in NP cells 
transfected with ARNT, ARNT2, and BMAL1 (150 ng/ each) with or without 25 ng of HIF-1α following 24 h culture in hypoxia or 
normoxia. Co-transfection of BMAL1 and ARNT but not ARNT2 with HIF-1α significantly increased the activity of HRE compared to 
HIF-1α alone. c.-F. Evaluation of HRE activity in NP cells co-transfected with increasing dose of BMAL1(C, D) or ARNT (E, F) with 25 
ng of HIF-1α, after 24 h hypoxia and normoxia treatment. The HRE activity showed a significant increase at highest dose of BMAL1 and 
ARNT compared to HIF-1 alone. Data is represented as mean ± SE, n=3, * p<0.05. 
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Figure 3: BMAL1 controls HIF-1 activity without affecting HIF-α-TAD function. A. Evaluation of BMAL1 and RORα 
expression by Western blot in NP cells stably transduced with lentivirus expressing BMAL1 shRNA. b., c. Densitometric analysis of 
multiple blots shown in (A) demonstrated decreased BMAL1 (B) and RORα (C) expression in BMAL1-silenced cells under both normoxia 
and hypoxia. d. HRE activity of BMAL1-silenced NP cells is significantly lower than cells transduced with control shRNA. e.-G. 
Evaluation of BMAL1 control of HIF-α-TAD function. BMAL1 overexpression had no effects on HIF-1α-C-TAD (E), HIF-1α-N-TAD (F), 
as well as HIF-2α-TAD (G) regardless of oxygen tension. Data is represented as mean ± SE, n= 3, * p<0.05.
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Figure 4: RORα controls HIF transcriptional activity and TAD function in NP cells. A., b. Evaluation of HRE activity in NP 
cells transfected with 50-150 ng of RORα with or without 25 ng of HIF-1α, after 24 h hypoxia and normoxia treatment. Under normoxia, 
compared to HIF-1α alone, cells co-transfected with RORα and HIF-1α showed a significant increase in HRE activity at all doses, while 
under hypoxia this increase was seen at 150 ng of RORα. c., d. Treatment of NP cells with increasing dose of highly specific, small 
molecular RORα inhibitor, ML176 (2-10 µM), resulted in decrease in activity of endogenous HIF protein under both normoxia (C) and 
hypoxia (D). e.-G. Regulation of HIF-α-TAD function by RORα in NP cells. Treatment with ML176 (10 µM) under both normoxia and 
hypoxia resulted in decrease in HIF-1α-C-TAD (E), HIF-1α-N-TAD (F) as well as HIF-2α-TAD (G) activities. Data is represented as mean 
± SE, n=3, *p<0.05. 
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with ML176. Interestingly, inhibitor treatment resulted in 
a decrease in HIF-1α-C-TAD (Figure 4E), HIF-1α-N-TAD 
(Figure 4F) as well as HIF-2α-TAD (Figure 4G) activities, 
suggesting that RORα may affect HIF-1α transactivation. 
BMAL1 and RORα do not bind to HIF-1α in NP 
cells
Given that BMAL1 and RORα control HIF-1α 
activity and function, we investigated the possibility 
of direct protein-protein interaction between BMAL1, 
RORα and HIF-1α. Surprisingly, immunoprecipitation of 
BMAL1 as well as CLOCK in NP cells did not result in 
pulldown of HIF-1α (Figure 5A). As expected, BMAL1 
evidenced binding with CLOCK and immunoprecipitation 
of CLOCK resulted in co-precipitation of BMAL1 (Figure 
5A). We also performed immunoprecipiation of HIF-1α to 
confirm these findings (Figure 5B). In line with BMAL1 
and CLOCK IP results, we were unable to detect co-
precipitation of BMAL1, CLOCK or RORα following 
pulldown of HIF-1α (Figure 5B). Again, HIF-1α was 
seen to associate with HIF-1β/ARNT (Figure 5C). These 
findings suggest that BMAL1 and RORα may not bind to 
HIF-1α or that the binding is highly transient. In order to 
determine if RORα affects HIF-1α levels and translocation 
in NP cells, we measured nuclear levels of HIF-1α 
following RORα inhibition under hypoxia. Western blot 
and corresponding densitometric analysis clearly shows 
that treatment of NP cells with ML176 for up to 24 hours 
has no apparent effect on nuclear levels of HIF-1α under 
hypoxic conditions (Figure 5D, 5E). 
BMAL1 and RORα inhibition results in decreased 
expression of select HIF-1 target genes 
To confirm that suppression of BMAL1 and RORα 
affects HIF target gene expression, we measured mRNA 
expression of select HIF-1 target genes following stable 
silencing of BMAL1 and pharmacological inhibition of 
RORα activity. qRT-PCR analysis showed that knockdown 
of BMAL1 resulted in a significant decrease in VEGF-A, 
enolase 1 (Eno1), PFKFB3 and RORα under both hypoxia 
and normoxia (Figure 6A). Similarly, treatment of NP 
cells with an RORα inhibitor resulted in decreased mRNA 
expression of BMAL1, VEGF, PFKFB3 and Eno1 under 
both hypoxia and normoxia (Figure 6B). Interestingly, 
however, the expression of other known HIF-1 target 
genes, PHD2 and PHD3 (not shown), remained unaffected 
in BMAL1 silenced and ML176 treated NP cells.
bMAl1 knockout mice evidence compromised 
disc height and vertebral bone parameters
Since BMAL1 affected HIF-1 activity in NP cells, 
and HIF-1 is necessary for proper functioning of the 
intervertebral disc, we wanted to investigate the effects 
of BMAL1 loss on the phenotype of post-natal spines. 
We analyzed the lumbar disc height of BMAL1 knockout 
(KO) mice (10 week old) and their wild type littermates 
using micro-computed tomography (µCT) (Figure 
7A). Parameters of disc height and vertebral bone were 
measured and averaged from the lumbar spine (L1-L5). 
The average of three disc height measurements (ventral, 
center and dorsal) and disc height index (DHI) were 
significantly lower in BMAL1-KO than BMAL1-WT mice 
(Figure 7B, 7C), suggesting that in vivo loss of BMAL1 
results in thinner discs. We also investigated the effects of 
BMAL1 loss on vertebral bone health. BMAL1-KO mice 
showed significant decreases in trabecular bone volume 
(BV), total volume (TV), bone volume fraction (BV/TV), 
trabecular number (Tb.N), and trabecular thickness (Tb. 
Th), and a significant increase in trabecular separation (Tb. 
Sp) (Figure 7D-7H). However, the connectivity density 
(Conn. dens) was not significantly different between WT 
and KO animals (Figure 7I). These results indicate that 
the vertebral bodies, in addition to the intervertebral discs, 
of BMAL1-KO animals are smaller than wild type and 
that the bone quality is inferior to the wild type animals. 
Noteworthy, loss of BMAL1 has a stronger effect on 
discs compared to the vertebral bodies, because the disc 
height index is significantly reduced in KO animals 
(Figure 7B). In addition, we evaluated the histological 
appearance of NP and lamellar structures of the annulus 
fibrosus (AF) (Figure 8A-8H). Not surprisingly, NP of 
BMAL1 null mice did not phenocopy that of NP-specific 
HIF-1α-deficient mice, in that NP cells of BMAL1 null 
mice remained viable post-natally [13]. However, analysis 
showed that BMAL1-KO animals have lower matrix-to-
cell ratio (Figure8C, 8D, and 8G), whereas in WT animals 
this ratio was higher (Figure 8A, 8B and 8E). Moreover, 
AF tissue in BMAL1-KO (Figure 8G, 8H) evidenced 
hyperplasia (Figure 8E, 8F) though the fiber orientation 
did not show obvious differences between WT and KO.
dIscussIon
BMAL1 (brain and muscle ARNT-like1), CLOCK 
and HIF-α are basic helix-loop-helix-PAS (bHLH-
PAS) transcriptional factors that share similarities in 
their bHLH and PAS dimerization domains [22, 30]. 
Canonically, BMAL1 acts through heterodimerization 
with CLOCK, and binding to E-box motifs -CACGTG 
in target gene promoters [17, 18], while HIF-α binds 
to its partner HIF-1β/ARNT to transcribe targets that 
allow cellular adaptation to hypoxia. A few reports have 
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Figure 5: BMAL1 and RORα do not bind to HIF-1α in NP cells. A. Immunoprecipitation (IP) of BMAL1 and CLOCK from 
NP cells cultured under normoxia or hypoxia for 24 h followed by Western blot analysis using anti-HIF-1α, anti-BMAL1 and anti-CLOCK 
antibodies. BMAL1 bound to CLOCK, but neither BMAL1 nor CLOCK bound to HIF-1α irrespective of oxygen tension. Preimmune 
rabbit IgG was used as a negative control for IP assays. b. Pulldown of HIF-1α did not show co-precipitation of BMAL1, CLOCK, or 
RORα. HC: heavy chain of IgG, nsp: non-specific (c) Pulldown of HIF-1α showed co- precipitation of HIF-1β/ARNT, association was 
higher under hypoxia. d., e. Treatment of NP cells with RORα inhibitor, ML-176 (10 µM), showed no effect on nuclear levels of HIF-1α. 
Densitometric analysis shown in (E) was performed on blots from 3 independent experiments, Data is represented as mean ± SE, * p < 0.05. 
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described a non-canonical function of BMAL1, dimerizing 
with HIF-1α under hypoxia, and activating transcription 
through binding to HRE motifs [23-25]. However, this 
hypoxia and HIF-dependent role of BMAL1 seems to 
be cell-type specific [31]. Since HIF-1α is necessary for 
NP cell survival in the hypoxic niche [13], we sought 
to investigate the potential role of the circadian master 
regulator BMAL1 in controlling HIF-1 function in the 
intervertebral disc. 
In our findings, BMAL1 overexpression alone did 
not change HRE activity. Noteworthy, co-transfection of 
BMAL1 with HIF-1α increased HRE activity compared 
with HIF-1α expression alone. This suggests that BMAL1 
in NP cells can cooperate with HIF-1α to activate HRE 
mediated transcription. Interestingly, our evaluation of 
HIF-TAD domains indicated that BMAL1 overexpression 
did not modulate recruitment of other co-factors by HIFs. 
Surprisingly, immunoprecipitation results showed neither 
BMAL1 nor CLOCK bound to HIF-1α, suggesting 
either lack of binding or a very transient nature of their 
interaction. These results are also in agreement with a 
report by Ghorbrl et al. demonstrating that BMAL1, 
CLOCK and HIF-1α cooperatively affected transcriptional 
regulation of vasopressin without heterodimerization 
[25]. It is therefore not unreasonable to assume that in NP 
cells BMAL1 activates HIF-1α function without direct 
dimerization. 
To further assess the function of the BMAL1-
HIF axis in NP, we evaluated HIF activity in BMAL1-
silenced NP cells. Downregulation of HRE activity in 
BMAL1-silenced NP cells demonstrates that BMAL1 
controls HIF-1α activity. Importantly, when BMAL1 
expression was suppressed, VEGF-A, Eno1 and PFKFB3 
mRNA expression were downregulated. These three HIF-
1 targets have been reported to contain E-box motif in 
their promoters and are sensitive to BMAL1 mediated 
regulation. A direct BMAL1 interaction with the E-Box 
has also been demonstrated in the case of VEGF-A 
promoter [32-35]. Noteworthy, the relationship between 
E-box motif and HRE sequence has been reported; 
although HIF-1 binding does not usually occur at the 
palindromic E-box, high percentage of rat, mouse and 
human gene promoters with functionally validated 
HREs overlap with predicted E-boxes [36-38]. These 
reports implicate that binding of BMAL1:CLOCK to the 
E-box sequences in gene promoters may affect HIF-1α 
recruitment and activity at nearby or overlapping HRE 
sites, effectively regulating its target gene expression.
Furthermore, we investigated the role of RORα 
in NP cells. It has been well known that RORα is an 
important regulator of BMAL1, and they regulate each 
other’s expression via a feedback loop [15, 19, 20]. Our 
Figure 6: BMAL1 and RORα inhibition results in decreased expression of select HIF-1 target genes. A.-b. qRT-PCR 
analysis of mRNA expression of select HIF-1 target genes following stable silencing of BMAL1 (A) or pharmacological inhibition of 
RORα activity by ML176 (10 µM) treatment. Knockdown of BMAL1 resulted in significant decrease in VEGF-A, enolase 1 (Eno1), 
PFKFB3 as well as RORα under both normoxia and hypoxia. B. NP cells treated with RORα inhibitor showed decreased mRNA expression 
of BMAL1, VEGF, PFKFB3 and Eno1. Expression of PHD2, another known HIF-1 target gene, remained unaffected in BMAL1 silenced 
and ML176 treated NP cells. Data is represented as mean ± SE. n=5, *p<0.1.
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Figure 7: BMAL1 knockout mice (KO) evidence compromised disc height and vertebral bone health. A. Representative 
µCT scans of lumbar spine (L1-L5) of a wild type and a KO littermate (10 week). Left panels show a coronal cut-plane through 3D 
reconstructions of the full lumbar segments of a WT and BMAL1 KO animal, showing changes in DHI. The right panels show a 
representative 3D reconstruction of ROI chosen for the bone trabecular morphometric analysis of each vertebral body showing changes in 
trabecular bone. The ROI contour only the outer boundary of the trabecular bone, excluding the cortical bone.  b., c. The average of three 
disc height measurements (ventral, center and dorsal) (B) and disc height index (DHI) (C) were significantly lower in BMAL1-KO mice. 
d.-H. BMAL1 KO animals showed significant decreases in trabecular bone volume (BV) and total volume (TV) (D), bone volume fraction 
(BV/TV) (E), trabecular number (Tb.N) (F), and trabecular thickness (Tb. Th) (G), and a significant increase in trabecular separation (Tb. 
Sp) (H). I. Connectivity density (Conn. dens) was unaffected in KO animals. Data is represented as mean ± SE. n = 4 animals/genotype, 5 
lumber vertebrae were measured/animal, *p<0.05. 
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Figure 8: bMAl1 null mice shows altered disc morphology. A.-d. Representative images of H&E and alcian blue staining of 
sagittal sections of lumbar disc from WT and KO mice. Compared to that of WT animals (A, B) NP tissue in null animals show decreased 
accumulation of matrix (lower matrix-to-cell ratio) (C, D), Scale bars: A, C: 50 μm, B, D: 10 μm. Disc height on images is outlined with 
dotted line. e.-H. Representative image of Picosirius red staining of WT and KO under bright field (E, G) and polarized light (F, H). 
Annulus fibrosus (AF) tissue in KO animals showed hyperplasia and increased thickening (white arrow). Scale bars: 100 μm.
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results that show decreased BMAL1 mRNA in RORα 
inhibitor treated cells and suppressed RORα protein and 
mRNA in BMAL1-silenced NP cells clearly support 
an inter-relationship between BMAL1 and RORα. 
Importantly, similar to BMAL1, RORα promoted HIF-1α-
dependent HRE activity under hypoxia. A previous study 
with NIH3T3 cells reported that the DNA-binding domain 
of RORα directly interacted with the inhibitory domain 
of HIF-1α, increasing its stability [26]. However, our 
immunoprecipitation experiments did not support an overt 
RORα-HIF-1α interaction in NP cells if any, suggesting 
a possible cell-type specific characteristic. Together these 
results indicate that RORα influences HIF-1α activity 
plausibly without a direct protein-protein interaction 
between them. Interestingly, inhibition of RORα activity 
by ML176 resulted in a decreased HIF-1α-TAD activity 
as well as mRNA expression of VEGF-A, PFKFB3, Eno1, 
and BMAL1. These findings indicate that RORα may 
affect HIF-1 activity and target gene expression in NP cells 
through modulating co-factor recruitment. Since BMAL1 
and RORα coregulate each other’s expression, they are 
likely to influence HIF-1α in a cooperative fashion. 
Our studies show for the first time that BMAL1 
and RORα, two important molecules in circadian rhythm 
machinery, are involved in the regulation of HIF-1α 
transcriptional function in NP cells through an indirect 
mechanism. In fact, the evaluation of BMAL1 KO mice 
demonstrated that BMAL1 is important for maintenance of 
discs and vertebral health. Both disc height and vertebral 
volume were smaller in BMAL1 KO mice compared to 
WT. Importantly, DHI of BMAL1 KO was also decreased, 
indicating a more crucial role for BMAL1 in maintenance 
of disc health compared to vertebral bodies. These results 
complimented the studies that showed early aging in other 
tissues from BMAL1 deficient mice [39]. It was also not 
surprising to see that NP phenotype of BMAL1 null mice 
did not phenocopy that of NP-specific HIF-1α-deficient 
mice, where NP cells die postnatally [13]. Since BMAL1 
co-regulated only a subset of HIF-1 target genes in NP 
cells, and because it is one of many regulators of HIF-1α 
function, lack of NP cell death is to be expected. Thus, 
this observation suggests that BMAL1 is dispensable 
for survival of notochordal NP. Still, histological studies 
of BMAL1 null mice showed decreased matrix-to-cell 
ratio in post natal NP. This implicated a possible delay in 
maturation and decreased secretion of proteoglycan rich 
matrix by notochordal cells that give rise to adult NP [40]. 
Whether this NP phenotype is due to modulation of HIF-
1 transcriptional activity controlling cell proliferation and 
differentiation in NP cells [41] or due to BMAL1 function 
independent of HIF-1 remains to be seen. In contrast to 
the effects on NP compartment, AF tissue in BMAL1 null 
mice evidenced hyperplasia, suggesting that the effects 
of BMAL1 deletion are tissue specific. Relevant to this 
discussion, in a recent study Numaguchi et al. showed 
that rats exposed to passive cigarette smoking for 8 weeks 
showed a significant alteration in many clock-related 
genes in both AF/CEP and NP tissues of the intervertebral 
disc [42]. Importantly, in discs these clock genes showed 
expression patterns consistent with a circadian rhythm, 
with several genes including Per1, Per2, Cry1, Nr1d1 
and Npas2, clearly evidencing a phase shift of anywhere 
between 3 to 9  h due to smoking. Significantly, BMAL1 
and another clock gene, Dbp, demonstrated complete 
abrogation of oscillation in the NP in smoke exposed 
animals [42]. Since smoking is considered an important 
risk factor for disc degeneration, and has been shown 
to promote NP cell dysfunction and matrix deposition 
[43,44], it is plausible that some of the pathological 
changes seen in disc in these smoke exposed animals may 
be attributed to altered clock gene activity. Taken together, 
our results suggest that BMAL1 and RORα regulate HIF-1 
activity in NP cells and play an important role in overall 
adaptation of NP cells to their hypoxic niche, and their 
dysregulation affects normal tissue homeostasis and 
function. Further investigations on the contribution of 
BMAL1 in progression of disc degeneration are under 
way.
MAterIAls And MetHods
Plasmids and reagents 
Plasmids were kindly provided by Dr. Taku Saito, 
University of Tokyo, Japan (HA-ARNT, -ARNT2, and 
-BMAL1) [27], Dr. Ren Xu, University of Kentucky, 
Lexington (pCDH1-RORα-flag) [45], and Dr. Vijay 
K. Yechoor, Baylor College of Medicine, Houston 
(Lentiviral shBMAL1) [46]. HIF-1α-C-TAD, aa740-
826; HIF-1α-N-TAD, aa 530-778; and HIF-2α-TAD, 
aa 819–870 were provided by Dr. Nianli Sang, Drexel 
University, Philadelphia, PA. pFR-Luc (Stratagene) 
reporter contains the firefly luciferase gene. psPAX2 (# 
12260) and pMD2G (#12259) developed by Dr. Didier 
Trono and HRE-Luc (#26731) were obtained from 
Addgene’s repository. For internal transfection control, 
vector pRL-TK (Promega) containing Renilla reniformis 
luciferase gene was used. RORα inverse agonist ML176 
was purchased from Cayman Chemical (Michigan). This 
selective inverse agonist competitively blocks the binding 
of 25-hydroxycholesterol to the ligand-binding domain 
of RORα and inhibits transactivation function. Spines of 
BMAL1-/- mice (9-10 weeks old) were kindly provided 
by Dr. Vijay Yechoor [46]. These mice were generated 
by breeding of Bmal1+/- on a C57Bl/6J background and 
maintained under 12:12 Light/Dark cycles, with lights on 
at 7 AM—Zeitgeber Time 0 (ZT-0) under ad lib access to 
food and water. 
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Isolation of nP cells, cell treatments and hypoxic 
culture
Rat (Sprague-Dawley, 10 week old) or mouse 
(C57Bl/6J, 10 week old) NP cells were isolated using 
a method reported earlier by Risbud et al. [8]. Animals 
were maintained under 12:12 Light/Dark cycles with ad 
lib access to food and water. Cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) and 10% 
fetal bovine serum (FBS) supplemented with antibiotics, 
and cultured in a Hypoxia Work Station (Invivo2 300, 
Ruskinn, UK) with a mixture of 1% O2, 5% CO2 and 94% 
N2 for 8-72 h.
rnA isolation and real time rt-Pcr Analysis
For analysis of BMAL1 and RORa in disc 
compartments, NP and AF tissues were isolated from 
adult Sprague-Dawley rats and immediately incubated in 
RNAlater (Thermofisher, AM7021) at 4oC. NP tissue was 
transferred to lysis buffer and homogenized with a Pellet 
Pestle Motor (Sigma Aldrich, Z359971) for 1 minute. AF 
tissue was frozen in liquid nitrogen and pulverized with 
a BioPulverizer (BioSpec). Pulverized AF tissue was 
transferred to TRIzol Reagent (Lifetechnologies) and 
DNA-RNA was isolated according to Lifetechnologies 
protocol and a DNA-free kit (Lifetechnologies). Total 
RNA was extracted from NP cells and NP tissue lysates 
using RNAeasy mini columns (Qiagen). Before elution 
from the column, RNA was treated with RNase free 
DNase I (Qiagen). The purified, DNA-free RNA was 
converted to cDNA using EcoDry™ Premix (Clontech). 
Template cDNA and gene-specific primers were added to 
Power SYBR Green master mix (Applied Biosystems) and 
mRNA expression was quantified using the Step One Plus 
Real-time PCR System (Applied Biosystems). HPRT1 was 
used to normalize gene expression. Melting curves were 
analyzed to verify the specificity of the RT-PCR and the 
absence of primer dimer formation.
transfections and dual luciferase assay
Cells were transferred to 48-well plates (2×104 cells/
well) one day pre-transfection. Cells were transfected 
with 175 ng HRE luciferase reporter with or without 25 
ng of HA-HIF-1α and 0-150 ng of ARNT or ARNT2, or 
BMAL1 or RORα or empty backbone plasmids and 150 
ng pRL-Tk, and reporter activities measured following 
culture under normoxia or hypoxia for 24 h. To measure 
effect of RORα inhibition on HIF-1 activity, cells were 
transfected with HRE reporter and activity measure after 
treatment with 0-10 μM ML176 for 24 h. To measure 
effect on HIF transactivation, cells were cotransfected with 
HIF-α-TAD plasmids (25 ng each) with or without 150 ng 
of BMAL1, and activity measured following normoxic or 
hypoxic culture for 24 h. TAD activity was also measured 
by treating cells with RORα inhibitor ML176 (10 µM) 
for 24 h. In all experiments, plasmids were premixed 
with the transfection reagent, LipofectAMINE2000 
(Invitrogen). The next day, cells were harvested and 
Dual-Luciferase™ reporter assay system (Promega) was 
used for measurements of firefly and Renilla luciferase 
activities using a luminometer (TD-20/20, Turner Designs 
CA).
Protein extraction, nuclear fractionation and 
Western blotting and Immunoprecipitation
Cells were immediately placed on ice and washed 
with ice-cold PBS. All wash buffers and the final 
resuspension buffer included 1x protease inhibitor mixture 
(GE Healthcare), NaCl (150 μM), β-glycerophosphate 
(62.5 mM), DTT (0.1 μM), NaF (5 mM), and Na3VO4 
(200 μM). When needed, CelLytic NuCLEAR extraction 
kit (Sigma Aldrich) was used to generate nuclear proteins. 
Immunoprecipitation was performed using Protein A/G 
PLUS-Agarose beads (SantaCruz) following standard 
protocol. Proteins were resolved on 8–12% SDS-
polyacrylamide gels and transferred by electroblotting 
to PVDF membranes (Bio-Rad). The membranes were 
blocked with 5% nonfat dry milk in TBST (50 mM Tris 
pH 7.6 with 0.1% Tween 20) and incubated overnight 
at 4°C in 5% nonfatdry milk in TBST with antibody. 
Immunolabeling was detected using the ECL reagent 
(Amersham Biosciences). Relative expression levels 
were determined by quantitative densitometric analysis 
using one-dimensional image analysis software (GE 
Healthsciences). Antibodies used were anti-BMAL1 
(#14020, Cell Signaling), anti-CLOCK (#5157, Cell 
Signaling; #3517, Abcam), anti-RORα (#NBP1-52813, 
Novus), anti-HIF-1α (#MAB1536, R&D Systems; 
#ab2185, Abcam), anti-HIF-1β/ARNT (#5537, Cell 
Signaling), anti-GAPDH (#NB300-221SS, Novus) and 
anti-Lamin A/C (#2032, Cell Signaling). 
lentiviral production and transduction
HEK 293T cells were seeded in 10-cm plates (5×106 
cells/plate) in DMEM with 10% heat-inactivated FBS one 
day before transfection. Cells were transfected with 9 μg 
of shBMAL1 or pGIPZ plasmids along with 6 μg psPAX2 
and 3 μg pMD2G using Calcium phosphate transfection 
kit (CalPhos, Clontech). After 16 h, transfection medium 
were removed and replaced with DMEM with 10% heat-
inactivated FBS. Lentiviral particles were harvested at 
48 and 60 h post-transfection. NP cells in 10 cm plates 
were transduced with 8 ml of medium containing viral 
particles with 6 μg/ml Polybrene. After 24 h, viral media 
was removed and replaced with DMEM with 10% FBS. 
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5 days after viral transduction, cells were used for protein 
and mRNA evaluation.
Micro-computed tomography analysis of bMAl1 
knockout mouse spine
Micro-computed tomography scans (MicroCT40, 
SCANCO Medical, Switzerland) were performed 
on spines of BMAL1-/- and wild type mice (n=4/
genotype) fixed with 4% PFA. Segments of lumbar spine 
incorporating L1-L5 were scanned with an energy of 
70 kVp, a current of 114 mA, and a 200-ms integration 
time producing a resolution of 16 mm3 voxel size. The 
cross sectional scans were analyzed to quantify changes 
in trabecular bone microarchitecture by first drawing 
regions of interest (ROI) that contour the outer boundary 
of the trabecular bone, excluding the cortical bone. 
The ROI were then compiled into 3D data sets using a 
Gaussian filter (σ = 1.0, support = 1) to reduce noise, 
and converted to binary images with a fixed grey-scale 
threshold of 200. The 3D data sets were assessed for 
the following parameters using software supplied by the 
system manufacturer: trabecular bone volume (BV), total 
volume (TV), bone volume ratio (BV/TV), trabecular 
thickness (Tb. Th), trabecular number (Tb.N) trabecular 
separation (Tb. Sp), connectivity density (Conn.dens.) 
and disc height between each vertebra. Disc height was 
determined by measurements made in three areas of the 
disc space: on the ventral, central and dorsal side, and 
an average of these values. Disc height index (DHI) was 
calculated by dividing average disc height by height of 
adjacent vertebral bodies. All heights were calculated by 
multiplying the number of cross sectional slices spanning 
the structure of interest by the known thickness of each 
slice.
Immunohistological analysis 
Following microCT spines were embedded 
in paraffin. Sagittal sections, 6-8 μm in thickness, 
were deparaffinized in xylene, rehydrated through 
graded ethanol and stained with alcian blue, eosin, and 
hematoxylin , or Picrosirius Red Stain kit TM (Polysciences, 
Inc.). For localizing BMAL1, sections of rat discs were 
incubated with the anti-BMAL1 antibodies (#AB 4140, 
Millipore) in 5% goat serum in PBS at 4°C overnight. 
After thoroughly washing the sections, the bound 
primary antibodies were incubated with Alexa fluor-594 
conjugated anti rabbit secondary antibody (Invitrogen) for 
1 h at room temperature. Sections were visualized using 
a fluorescence microscope (Axio Imager 2, Zeiss) or a 
polarizing microscope (Eclipse LV100 POL, Nikon). 
statistical analysis
All measurements were performed in triplicate, and 
data are presented as mean ± S.E. Differences between 
groups were analyzed by the Student’s t test and one-way 
ANOVA; p<0.05. 
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